How Much Money Will Moderna Make From Its COVID Vaccine?
The countdown is on. One week from today, an FDA advisory committee will review Moderna's (NASDAQ: MRNA) emergency use authorization (EUA) filing for COVID-19 vaccine candidate mRNA-1273. The FDA will then make a final EUA decision soon thereafter, taking the advisory committee's recommendation into consideration.
While anything can happen, it seems highly likely that mRNA-1273 will receive a green light from the FDA. That will pave the way for big bucks to begin flowing into Moderna's coffers. But just how much money will Moderna actually make from its COVID vaccine?
Image source: Getty Images.
Source Fool.com
